Journal de Mycologie Medicale

Papers
(The TQCC of Journal de Mycologie Medicale is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature86
Potent in vitro activity of curcumin and quercetin co-encapsulated in nanovesicles without hyaluronan against Aspergillus and Candida isolates33
Trichophyton indotineae, from epidemiology to therapeutic26
Critically ill patients with COVID-19 and candidaemia: We must keep this in mind24
Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy23
First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus22
Evaluation of the BioFire® FilmArray® Meningitis/Encephalitis panel in an adult and pediatric Ugandan population20
Earliest case of Candida auris infection imported in 2007 in Europe from India prior to the 2009 description in Japan20
Overview about Candida auris: What's up 12 years after its first description?19
Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report18
Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus18
Trends in the Prevalence of Amphotericin B-Resistance (AmBR) among Clinical Isolates of Aspergillus Species16
Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes – a tertiary care center experience16
Isolation and characterization of ergosterol from Monascus anka for anti-lipid peroxidation properties16
High colonization by Candida parapsilosis sensu stricto on hands and surfaces in an adult intensive care unit16
COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review15
The effectiveness of surface disinfectants and a micellic H2O2 based water disinfectant on Candida auris14
Invasive pulmonary aspergillosis in COVID-19 critically ill patients: Results of a French monocentric cohort14
Aspergillus peritonitis in peritoneal dialysis patients: A systematic review14
In vitro antifungal and antibiofilm activities of novel sulfonyl hydrazone derivatives against Candida spp.13
Epidemiology of candidemia in NICE area, France: A five-year study of antifungal susceptibility and mortality13
COVID-19 and Candida duobushaemulonii superinfection: A case report13
Essential oils and their components in combating fungal pathogens of animal and human skin12
Multidrug resistant tinea corporis/cruris: Response to voriconazole12
Invasive fungal infections among critically ill adult COVID-19 patients: First experiences from the national centre in Hungary12
Anti-Candida activity of the water-soluble lectin from Moringa oleifera seeds (WSMoL)12
Epidemiology, risk factors and antimicrobial profile of Vulvovaginal Candidiasis (VVC): A study among women in the central region of Saudi Arabia11
A systematic review of epidemiology, risk factors, diagnosis, antifungal resistance, and management of invasive aspergillosis in Africa11
Estimates of serious fungal infection burden in Côte d’Ivoire and country health profile11
Invasive Candida kefyr infection presenting as pyelonephritis in an ICU hospitalized COVID-19 patient: Case report and review of the literature10
COVID-19 and invasive fungal coinfections: A case series at a Brazilian referral hospital10
Carnosol inhibits the growth and biofilm of Candida albicans9
Cryptococcosis in HIV-AIDS patients from Southern Brazil: Still a major problem9
Determination of dermatophytes isolated from tinea capitis using conventional and ITS-based sequencing methods in Kano, Nigeria.9
Identification of Malassezia species isolated from some Malassezia associated skin diseases9
Coronavirus disease and candidemia infection: A case report9
Mucormycosis: A killer in the shadow of COVID-199
Can the essential oil of rosemary (Rosmarinus officinalis Linn.) protect rats infected with itraconazole-resistant Sporothrix brasiliensis from fungal spread?9
Candida nivariensis: Identification strategy in mycological laboratories9
Combination therapy in Mucormycosis: Current evidence from the world literature, a mini review8
Prevalence and species distribution of microorganisms isolated among non-pregnant women affected by vulvovaginal candidiasis: A retrospective study over a 20 year-period8
Review: Emergomycosis8
Clinical characteristics and risk factors of in-hospital mortality in patients coinfected with Pneumocystis jirovecii and Aspergillus8
Physiological characterization and molecular identification of some rare yeast species causing onychomycosis8
Antifungal sensitivity and species of yeasts in oral mucosa of street mixed-breed dogs8
COVID-19-associated mucormycosis in India: Why such an outbreak?8
Tinea capitis at the University Hospital of Tizi-Ouzou, Algeria, and first isolation of Trichophyton tonsurans8
Review on host-pathogen interaction in dermatophyte infections8
Fungal diseases in Africa: Closing the gaps in diagnosis and treatment through implementation research and advocacy8
Photodynamic therapy-mediated hypericin-loaded nanostructured lipid carriers against vulvovaginal candidiasis8
Human sporotrichosis outbreak caused by Sporothrix brasiliensis in a veterinary hospital in Southern Brazil8
Clinical features and outcome of patients with chronic pulmonary aspergillosis in China: A retrospective, observational study7
Black aspergilli as causes of otomycosis in the era of molecular diagnostics, a mini-review7
Impact of revised EORTC/MSGERC 2020 criteria on diagnosis and prognosis of invasive pulmonary aspergillosis in patients with hematological malignancies undergoing bronchoscopy7
Papiliotrema laurentii fungemia in a premature, very low-birth-weight neonate in Kuwait successfully treated with liposomal amphotericin B7
Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap7
Otomycosis in Africa: Epidemiology, diagnosis and treatment7
Molecular epidemiology of Trichophyton infections among canines from Northern India7
Simulated vaginal fluid: Candida resistant strains’ biofilm characterization and vapor phase of essential oil effect7
Epidemiology of Pityriasis versicolor in Tunisia: Clinical features and characterization of Malassezia species7
Kazachstania slooffiae: An unexpected journey to a human pleural sample7
Clinical profile, antifungal susceptibility, and molecular characterization of Candida auris isolated from patients in a South Indian surgical ICU.6
Efficacy and safety of echinocandin monotherapy and combination therapy for immunocompromised patients with systemic candidiasis: A systematic review and meta-analysis6
Disseminated histoplasmosis diagnosed by cross-reactivity with the Aspergillus galactomannan antigen in an HIV-positive patient6
Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study6
Differential inflammatory response to Aspergillus flavus and Candida albicans infection in human retinal pigment epithelial cells: Role in treatment of endophthalmitis6
Adhesion of Candida tropicalis to polystyrene and epithelial cell lines: Insights of correlation of the extent of adherent yeast cells among distinct surfaces6
Apophysomyces variabilis, an emerging and worrisome cause of primary cutaneous necrotizing infections in India6
Emerging issue of fluconazole-resistant candidemia in a tertiary care hospital of southern italy: time for antifungal stewardship program6
The challenge of access to refined fungal diagnosis: An investment case for low- and middle-income countries6
Diversity of Fusarium species causing invasive and disseminated infections6
Dermatophytosis caused by Nannizzia nana6
Activity of MSI-78, h-Lf1-11 and cecropin B antimicrobial peptides alone and in combination with voriconazole and amphotericin B against clinical isolates of Fusarium solani6
Current scenario of the search for new antifungal agents to treat Candida auris infections: An integrative review6
Survival of an immuno-competent patient from splenic and gastric mucormycosis-case report and review of the literature6
Mucormycosis in COVID-19: The Indian scenario5
Autochthonous case of Trichophyton indotineae in Kuwait5
Coincidence or reality behind Mucormycosis, diabetes mellitus and Covid-19 association: A systematic review5
Tuberculosis and neurocryptococcosis by Cryptococcus neoformans molecular type VNI in A non-HIV patient: A comorbidities case report5
Allergic bronchopulmonary aspergillosis: A multidisciplinary review5
Predisposing factors, clinical features and treatment outcomes of Fusarium onychomycosis and comparison of its characteristics with Neoscytalidium onychomycosis5
Candida albicans triggers qualitative and temporal responses in gut bacteria5
Keystone salivary mycobiome in postpartum period in health and disease conditions5
Clinical features of actinomycosis: A 20-year experience of a single institute in Southern China5
0.054892063140869